Use a separate syringe for each and inject at different sites
If more than five days have passed, skip the missed dose and take the next dose on your regular schedule
Prof Gs answer Q: The evidence regarding GLP-1 use and safety in people with MS YES Q: Whether the metabolic benefits alone justify considering them in someone with my profile YES For information on why I am saying yes and yes, the following is a more detailed discussion on the evidence of the therapeutic potential of GLP-1 receptor agonists in MS and what I think about the HCPs attitudes to your requests.
Arrive a few minutes early if its your first visit to complete a short intake form
Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais GR, HOPE and HOPE-TOO Trial Investigators
Alhouayek M